LOTEMAX SM FDA approval date
The FDA approved LOTEMAX SM on 22 Feb 2019.
- FDA approval date
- 22 Feb 2019
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as LOTEPREDNOL ETABONATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2019-02-22Day | LOTEMAX SM | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208219", "applicant_as_listed_by_fda": "BAUSCH AND LOMB INC", "brand_names": ["LOTEMAX SM"], "active_ingredients": ["LOTEPREDNOL ETABONATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190222", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |